Concomitant purification of prostatic carcinoma tumor markers from human seminal fluid under nondenaturing conditions
- PMID: 2461817
Concomitant purification of prostatic carcinoma tumor markers from human seminal fluid under nondenaturing conditions
Abstract
We report a protocol for concomitant purification to homogeneity of both prostatic acid phosphatase [orthophosphoric-monoester phosphohydrolase (acid optimum), EC 3.1.3.2] and prostate-specific antigen, from human seminal fluid. The method requires only two chromatographic steps: passage through an Affigel-Blue column and gel filtration HPLC. This is a fast, efficient procedure for purification of these two important tumor markers, which are specific for prostatic cancer.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials